epistaxis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Male or female patients aged 18 to 65 (inclusive); 2.Patients with nasal cavity bleeding / patients with post-operative nasal cavity bleeding, confirmed with active bleeding via nasal endoscopy, where light pressure cannot stop the bleeding; 3.Before implementing any research-related experimental steps, the subjects voluntarily sign the informed consent form and agree to undergo regular follow-up examinations;
Exclusion criteria
Exclusion criteria: 1.Severe hypertension that has not been controlled stably; 2.Patients with hepatic and renal insufficiency or abnormalities; 3.Cardiac disease (cardiac dysfunction of Class II or above); 4.Patients with immune dysfunction; 5.Alcoholism or long-term drug abuse; 6.Patients requiring long-term high-dose steroid treatment; 7.Physical or mental defects affecting treatment; 8.Individuals with blood disorders and coagulation dysfunctions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nasal bleeding condition; | — |
Secondary
| Measure | Time frame |
|---|---|
| comfort degree; | — |
Countries
China
Contacts
Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine